Prevalence of depression symptoms in patients with psoriasis in Argentina
Keywords:
psoriasis, depression, prevalenceAbstract
Background: depression is a very frequent mental disease and one of the principal causes of death in young people in our country. It affects 300 million people in the world and the WHO estimates a prevalence of 5% in Latin America and the Caribbean. Psoriasis is an inflammatory chronic disease, systemic and multifactorial, associated with multiple comorbidities. Numerous studies report the prevalence of this association, but until today there is no data in Argentina.
Objectives: the aim of this study is to estimate de prevalence of depression symptoms in psoriasis patients in our country and to compare it with the literature.
Design: transversal, observational and descriptive.
Methods: we include 200 patients with psoriasis that attended to the Dermatologic Unit of the Hospital Dr. Cosme Argerich between January 2014 and December 2015, who underwent the dermatologic medical
record, an epidemiological questionnaire and the Beck Depression Inventory (BDI-II).
Results: the prevalence of psoriasis symptoms was 92.5% (66.49% minimal symptoms, 18.38% mild, 9.73% moderate and 5.40% severe), without differences between the sexes, but more severe in women. Twenty one percent were self-reported depressed, although 76.19% of them only reach the mild level in the BDI-II.
Conclusion: the psoriasis patients of this serie presented a high prevalence of depression symptoms, higher than were found in the literature. Our study is an initial analysis of the psychiatric comorbidities of psoriasis patients, because there is no data in Argentina.
References
I. Sociedad Argentina de Dermatología. Consenso Nacional de Psoriasis. Guía De Tratamiento 2018. Disponible en: http:// www.sad.org.ar/wp-content/uploads/2016/04/Consenso-Psoriasis-2018-FINAL-14122018.pdf.
II. Picardi A, Abeni D. Stressful life events and skin diseases: Disentangling evidence from myth. Psychother Psychosom 2001;70:118-136.
III. Rieder E, Tausk F. Psoriasis, a model of dermatologic psychosomatic disease: Psychiatric implications and treatments. Int J Dermatol 2012;51:12-26.
IV. Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: A population-based cohort study. Arch Dermatol 2010;146:891-895.
V. Gupta MA, Schork NJ, Gupta AK, Kirkby S, et ál. Suicidal ideation in psoriasis. Int J Dermatol 1993;32:188-190.
VI. Eskin M, Şavk E, Uslu M, Küçükaydoğan N. Social problem-solving, perceived stress, negative life events, depression and life satisfaction in psoriasis. J Eur Acad Dermatology Venereol 2014;28:1553-1559.
VII. Organización Panamericana de la Salud. Depresión y otros trastornos mentales comunes. Estimaciones Sanitarias Mundiales 2017;1-24.
VIII. Patel N, Nadkarni A, Cardwell LA, Vera N, et ál. Psoriasis, Depression, and Inflammatory Overlap: A Review. Am J Clin Dermatol 2017;18:613-620.
IX. Mattei PL, Corey KC, Kimball AB. Cumulative life course impairment: Evidence for psoriasis. Curr Probl Dermatol 2013;44:82-90.
X. Egeberg A, Khalid U, Gislason GH, Mallbris L, et ál. Impact of depression on risk of myocardial infarction, stroke and cardiovascular death in patients with psoriasis: A danish nationwide study. Acta Derm Venereol 2016;96:218-221.
XI. Picardi A, Lega I, Tarolla E. Suicide risk in skin disorders. Clin Dermatol 2013;31:47-56.
XII. Picardi A, Mazzotti E, Pasquini P. Prevalence and correlates of suicidal ideation among patients with skin disease. J Am Acad Dermatol 2006;54:420-426.
XIII. Yur’yev A, Värnik A, Värnik P, Sisask M, et ál. Employment status influences suicide mortality in Europe. Int J Soc Psychiatry 2012;58:62-68.
XIV. Beck A, Steer R, Brown G. Capítulo 2. Administración y puntuación del BDI-II. En: BDI-II Inventario de Depresión de Beck, 2.ª ed. Buenos Aires: Paidós; 2006:49-56.
XV. Łakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezińska-Wcisło L. The relationship between psoriasis and depression: A multiple mediation model. Body Image 2016;19:126-132.
XVI. Remröd C, Sjöström K, Svensson Å. Pruritus in psoriasis: A study of personality traits, depression and anxiety. Acta Derm Venereol 2015;95:439-443.
XVII. Esposito M, Saraceno R, Giunta A, Maccarone M, et ál. An Italian study on psoriasis and depression. Dermatology 2006;212:123-127.
XVIII. Heydendael VMR, De Borgie CAJM, Spuls PI, Bossuyt PMM, et ál. The burden of psoriasis is not determined by disease severity only. J Investig Dermatology Symp Proc 2004;9:131-135.
XIX. Wojtyna E, Łakuta P, Marcinkiewicz K, Bergler-Czop B, et ál. Gender, body image and social support: Biopsychosocial determinants of depression among patients with psoriasis. Acta Derm Venereol 2017;97:91-97. 20
XX. Remröd C, Sjöström K, Svensson A. Psychological differences between early- and late-onset psoriasis: A study of personality traits, anxiety and depression in psoriasis. Br J Dermatol 2013;169:344-350.
XXI. Ferrándiz C, Pujol RM, García-Patos V, Bordas X, et ál. Psoriasis of early and late onset: A clinical and epidemiologic study from Spain. J Am Acad Dermatol 2002;46:867-873.
XXII. Stewart TJ, Tong W, Whitfeld MJ. The associations between psychological stress and psoriasis: a systematic review. Int J Dermatol 2018;57:1275-1282.
XXIII. Devrimci-Ozguven H, Kundakci N, Kumbasar H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatology Venereol 2000;14:267-271.
XXIV. Altobelli E, Maccarone M, Petrocelli R, Marziliano C, et ál. Analysis of health care and actual needs of patients with psoriasis: A survey on the Italian population. BMC Public Health 2007;7:1-7.
XXV. Molina-Leyva A, Jiménez-Moleõn JJ, Naranjo-Sintes R, Ruiz-Carrascosa JC. Sexual dysfunction in psoriasis: A systematic review. J Eur Acad Dermatology Venereol 2015;29:649-655.
XXVI. Molina-Leyva A, Almodovar-Real A, Carrascosa JCR, Molina-Leyva I, et ál. Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis. An Bras Dermatol 2015;90:338-345.
XXVII. Rapp SR, Exum ML, Reboussin DM, Feldman SR, et ál. The physical, psychological and social impact of psoriasis. J Health Psychol 1997;2:525-537.
XXVIII. Singh S, Taylor C, Kornmehl H, Armstrong AW. Psoriasis and suicidality: A systematic review and meta-analysis. J Am Acad Dermatol 2017;77:425-440.e2.
XXIX. Strober B, Gooderham M, de Jong EMGJ, Kimball AB, et ál. Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR). J Am Acad Dermatol 2018;78:70-80.
Downloads
Published
Issue
Section
License
El/los autor/es tranfieren todos los derechos de autor del manuscrito arriba mencionado a Dermatología Argentina en el caso de que el trabajo sea publicado. El/los autor/es declaran que el artículo es original, que no infringe ningún derecho de propiedad intelectual u otros derechos de terceros, que no se encuentra bajo consideración de otra revista y que no ha sido previamente publicado.
Le solicitamos haga click aquí para imprimir, firmar y enviar por correo postal la transferencia de los derechos de autor
